Charles Adam Cluchey LPC

Recommended Articles

• Does Exercise Induce Asthma?

  Physical exertion continued for a long duration may trigger respiratory difficulties, which are referred to as exercise-induced asthma or exercise-induced bronchospasm. In most cases, the symptoms of this condition are experienced during exercise. The symptoms can even appear in people who do not...

• A Guide to Surviving the First Year of Nursing

  There are really no ways to describe all those feelings that a newly graduated nurse can feel.  From the pride of successfully reaching a goal to the excitement of landing that first nursing job and finally, the nervous jitters that come along with treating a patient for the first time as a...

• Saliva Test to Diagnose Lupus May Soon Exist

  Researchers have created a simplified technique to diagnose lupus using saliva. The initial research took place at the University of Houston, and was thanks to a $387,000 grant from the National Institutes of Health.  If successful, the saliva test could very well replace the invasive methods that...

• BPA from Soup Cans Shown to Increase Risk for Breast and Prostate Cancer

  A new study has shown that having a 12-ounce serving of canned soup a day for five days can lead to a 1000% increase in the amount of bisphenol A (BPA), a controversial chemical, in urine. BPA is a chemical used in the manufacturing of metal food and beverage cans. The study does not show how this...

• Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission

  4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...